Literature DB >> 18363757

Gene expression of cytokines in atopic eczema before and after ultraviolet A1 phototherapy.

T Gambichler1, A Kreuter, N S Tomi, N Othlinghaus, P Altmeyer, M Skrygan.   

Abstract

BACKGROUND: Atopic eczema (AE) is a common pruritic and chronically relapsing inflammatory skin disease in which cytokines seem to represent important factors in the pathogenesis.
OBJECTIVES: We aimed to investigate cytokine mRNA expression in the skin of patients with AE who underwent a course of ultraviolet A1 (UVA1) phototherapy.
METHODS: We studied 21 patients diagnosed with extrinsic AE who were treated with a 6-week course of UVA1 phototherapy. Skin biopsies were taken from healthy controls (n=18) and patients with AE at baseline and after the last UVA1 exposure. Quantitative real-time reverse transcriptase-polymerase chain reaction was performed for interleukin (IL)-4, IL-5, IL-10, IL-13 and IL-31.
RESULTS: A significant reduction of the clinical scores was observed after treatment with UVA1. Except for IL-4, cytokine mRNA expression was significantly increased prior to phototherapy when compared with controls. mRNA levels of IL-4 and IL-10 before UVA1 did not significantly differ from levels observed after UVA1. However, a significant decrease of IL-5, IL-13 and IL-31 mRNA expression was observed following UVA1 treatment. IL-31 mRNA levels were even adjusted to the levels of healthy controls.
CONCLUSIONS: We have shown that the resolution of extrinsic AE lesions following phototherapy is accompanied by significant reduction of mRNA expression of IL-5, IL-13 and IL-31, supporting current concepts that these cytokines play a crucial role in the pathogenesis of extrinsic AE and possibly represent targets for phototherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18363757     DOI: 10.1111/j.1365-2133.2008.08498.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response.

Authors:  Suzanne Tintle; Avner Shemer; Mayte Suárez-Fariñas; Hideki Fujita; Patricia Gilleaudeau; Mary Sullivan-Whalen; Leanne Johnson-Huang; Andrea Chiricozzi; Irma Cardinale; Shenghui Duan; Anne Bowcock; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2011-07-16       Impact factor: 10.793

Review 2.  IL-31: State of the Art for an Inflammation-Oriented Interleukin.

Authors:  Francesco Borgia; Paolo Custurone; Federica Li Pomi; Raffaele Cordiano; Clara Alessandrello; Sebastiano Gangemi
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

3.  Role of IL-31 in regulation of Th2 cytokine levels in patients with nasal polyps.

Authors:  Hong Ouyang; Jie Cheng; Yajun Zheng; Jingdong Du
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-11       Impact factor: 2.503

4.  The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis.

Authors:  Karolina Malinowska; Anna Woźniacka; Jarosław Bogaczewicz
Journal:  Postepy Dermatol Alergol       Date:  2019-10-07       Impact factor: 1.837

5.  Consensus Update for Systemic Treatment of Atopic Dermatitis.

Authors:  Ji Hyun Lee; Jung Eun Kim; Gyeong-Hun Park; Jung Min Bae; Ji Yeon Byun; Min Kyung Shin; Tae Young Han; Seung Phil Hong; Yong Hyun Jang; Hye One Kim; Chan Ho Na; Bark-Lynn Lew; JiYoung Ahn; Chang Ook Park; Young-Joon Seo; Yang Won Lee; Sang Wook Son; Eung Ho Choi; Young Lip Park; Joo Young Roh
Journal:  Ann Dermatol       Date:  2021-11-04       Impact factor: 1.444

Review 6.  Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis.

Authors:  Hae-Jin Lee; Seung-Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-21       Impact factor: 5.764

7.  Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis.

Authors:  Jarosław Bogaczewicz; Karolina Malinowska; Anna Sysa-Jedrzejowska; Anna Wozniacka
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.